Neuroscience

Scientists leverage the natural ability of antibodies to cross the blood-brain barrier and target proteins implicated in neurodegenerative disease.

Transplanted astrocyte precursor cells promote healing in mouse brains after white matter strokes.

Art therapy improved brain connectivity in patients with Parkinson’s disease, suggesting that creating art may help treat it and other neurodegenerative diseases.

Researchers used an innovative computational approach to identify a generic drug that could be repurposed to treat cocaine toxicity.

By fusing a brain-targeted antibody with an antibody that protects neurons from degeneration, scientists developed a new class of drugs that can traverse the blood brain barrier, enabling potential new treatments for Parkinson’s disease, Alzheimer’s disease, and depression.

A newly developed drug stabilizes dopamine and serotonin levels using a novel mechanism. It effectively treats psychosis in patients with schizophrenia, and researchers are testing its efficacy for Parkinson’s disease as well.

Scientists identified a new sex-specific pain circuit in the brain, laying the groundwork for developing better pain-relieving drugs for both sexes.

Spending an hour every day listening to a low-pitched thrum and gazing at blinking lights may help prevent structural changes in the brain and cognitive impairments associated with Alzheimer’s disease.

LIVE June 17th, 2021 at 2:30 PM ET
This webinar will discuss recent disease and drug discoveries enabled through screening CRISPR-modified stem cells.

LIVE May 25th, 2021 at 10:30 AM ET
This webinar will discuss new drug delivery approaches to overcoming the blood-brain barrier.